Suchergebnisse - "Ávalos Prado, Pablo"

PubPharm (12)

1

THERAPEUTIC USE OF CALCIUM-ACTIVATED CHLORIDE CHANNEL PEPTIDE ACTIVATOR

enthalten in: Europäisches Patentamt | 2023

von SANDOZ GUILLAUME | AVALOS PRADO PABLO | BARHANIN JACQUES

2

THERAPEUTIC USE OF CALCIUM-ACTIVATED CHLORIDE CHANNEL PEPTIDE ACTIVATOR

enthalten in: Europäisches Patentamt | 2023

von SANDOZ GUILLAUME | AVALOS PRADO PABLO | BARHANIN JACQUES

3

칼슘 활성화 클로라이드 채널 펩타이드 활성화제의 치료적 용도

enthalten in: Europäisches Patentamt | 2023

von SANDOZ GUILLAUME | AVALOS PRADO PABLO | BARHANIN JACQUES

4

Regulation of two-pore-domain potassium TREK channels and their involvement in pain perception and migraine

enthalten in: Neuroscience letters | 2022

von Ávalos Prado, P. | Chassot, A. | Landra-Willm, A. | +1

5

THERAPEUTIC USE OF CALCIUM-ACTIVATED CHLORIDE CHANNEL PEPTIDE ACTIVATOR

enthalten in: Europäisches Patentamt | 2022

von SANDOZ GUILLAUME | AVALOS PRADO PABLO | BARHANIN JACQUES

6

THERAPEUTIC USE OF CALCIUM-ACTIVATED CHLORIDE CHANNEL PEPTIDE ACTIVATOR

enthalten in: Europäisches Patentamt | 2022

von SANDOZ GUILLAUME | AVALOS PRADO PABLO | BARHANIN JACQUES

7

TREK channel activation suppresses migraine pain phenotype

enthalten in: iScience | 2021

von Ávalos Prado, P. | Landra-Willm, A. | Verkest, C. | +4

8

Migraine and Two-Pore-Domain Potassium Channels

enthalten in: The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry | 2021

von Verkest, C. | Häfner, S. | Ávalos Prado, P. | +2

9

KCNE1 is an auxiliary subunit of two distinct ion channel superfamilies

enthalten in: Cell | 2021

von Ávalos Prado, P. | Häfner, S. | Comoglio, Y. | +5

CommentIn: Cell. 2021 Jan 21;184(2):299-301. - PMID 33482096

10

TREK for High-Speed and High-Frequency Conduction through the Axon

enthalten in: Neuron | 2019

von Ávalos Prado, P. | Sandoz, G.

CommentOn: Neuron. 2019 Dec 4;104(5):960-971.e7. - PMID 31630908